白藜芦醇心血管保护机制的研究进展
[Research progress on cardiovascular protective mechanism of resveratrol].
作者信息
Wu Qian, Li Hui-Min, Yang Chun-Kun, Yang Ying-Tian, Wang Shi-Han
机构信息
Department of Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University Wuhan 430060, China.
出版信息
Zhongguo Zhong Yao Za Zhi. 2025 Jun;50(12):3244-3251. doi: 10.19540/j.cnki.cjcmm.20250213.703.
Resveratrol(Res) is a kind of polyphenolic compound, possessing multiple biological activities such as antioxidant, anti-inflammatory, cardioprotective, and anticancer effects. In recent years, the cardiovascular protective mechanism of Res has become a research hotspot. Studies have shown that Res has a protective effect on the cardiovascular system through various pathways, such as inhibiting oxidative stress, regulating ferroptosis of cells, improving ischemia-reperfusion(I/R) injury, regulating lipid metabolism, suppressing inflammatory responses, and enhancing endothelial function. It can also alleviate cardiotoxicity caused by drugs and chemicals. In terms of oxidative stress, Res reduces the level of intracellular reactive oxygen species(ROS) by enhancing the expression of proteins such as silent information regulator 1(SIRT1) and regulating mitochondrial function, thereby alleviating myocardial cell damage. Regarding ferroptosis, Res inhibits the occurrence of ferroptosis by regulating the expression of proteins related to iron metabolism. Res can also improve I/R injury through mechanisms such as activating autophagy and the mitochondrial quality control network. In regard to improving endothelial function, Res protects the function of endothelial cells by regulating multiple signaling pathways, such as downregulating the PREP1-mediated pathway. Res can also regulate lipid metabolism and inhibit the progression of atherosclerosis. In terms of inflammatory responses, Res exerts anti-inflammatory effects through mechanisms such as inhibiting the nuclear factor-kappa B(NF-κB) signaling pathway. In addition, Res has an improving effect on cardiotoxicity caused by different drugs or environmental factors. However, the clinical application of Res still faces limitations such as poor pharmacokinetic properties. In the future, in-depth exploration is needed at multiple levels from basic research to clinical application to clarify the dose-response relationship and standardize the standards of medication regimens with the expectation of providing more effective strategies for the prevention and treatment of cardiovascular diseases.
白藜芦醇(Res)是一种多酚类化合物,具有抗氧化、抗炎、心脏保护和抗癌等多种生物活性。近年来,Res的心血管保护机制已成为研究热点。研究表明,Res通过多种途径对心血管系统具有保护作用,如抑制氧化应激、调节细胞铁死亡、改善缺血再灌注(I/R)损伤、调节脂质代谢、抑制炎症反应以及增强内皮功能。它还可以减轻药物和化学物质引起的心脏毒性。在氧化应激方面,Res通过增强沉默信息调节因子1(SIRT1)等蛋白质的表达并调节线粒体功能,降低细胞内活性氧(ROS)水平,从而减轻心肌细胞损伤。关于铁死亡,Res通过调节铁代谢相关蛋白质的表达来抑制铁死亡的发生。Res还可以通过激活自噬和线粒体质量控制网络等机制改善I/R损伤。在改善内皮功能方面,Res通过调节多种信号通路,如下调PREP1介导的通路,来保护内皮细胞的功能。Res还可以调节脂质代谢并抑制动脉粥样硬化的进展。在炎症反应方面,Res通过抑制核因子-κB(NF-κB)信号通路等机制发挥抗炎作用。此外,Res对不同药物或环境因素引起的心脏毒性有改善作用。然而,Res的临床应用仍面临药代动力学性质差等局限性。未来,需要从基础研究到临床应用的多个层面进行深入探索,以明确剂量反应关系并规范用药方案标准,期望为心血管疾病的预防和治疗提供更有效的策略。